The PrisMax System is an advanced acute care technology solution designed to improve the delivery of continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) therapies for critically ill patients in the intensive care unit (ICU). Baxter, a leader in critical care expertise, collaborated with critical care experts to develop this next generation solution by gathering insights from more than 650 ICU healthcare professionals from more than 50 ICUs around the world.

The PrisMax System builds on over 20 years of critical care expertise and is designed to simplify the complexities of delivering CRRT, streamline clinician workflow, and improve the accuracy of treatment delivery and system performance. Its integrated features help monitor therapy setup and delivery, potentially reducing human error and enhancing patient safety.

By automating labor-intensive tasks, the PrisMax System helps healthcare professionals achieve more efficient treatment and reduce nursing burden. The system’s advanced technology enables clinicians to optimize therapy by providing individualized therapies for critically ill patients in the ICU, maximizing therapy delivery, and improving the quality of patient care now and in the future.

In summary, the PrisMax System is an innovative solution designed to address the greatest challenges faced by ICU healthcare professionals when delivering CRRT and TPE therapies. With its simplified therapy delivery, more efficient treatment, and improved accuracy, the system can help healthcare professionals achieve greater confidence in delivering critical care therapies, ultimately improving patient outcomes.

Facebook Page of the Product

Twitter Page of the Product

linkedin Page of the Product

Website of the Product